Alto Neuroscience, Inc. (ANRO) Ownership

$2.28

south_east
-$0.05 (-1.94%)
Day's range
$2.23
Day's range
$2.39

Alto Neuroscience, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ALPHA WAVE GLOBAL, LP 02/13/2025 3.71 M $15.68 M   0.00% 13.75%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 1.69 M $7.16 M   73.08% 6.28%
BLACKROCK, INC. 02/07/2025 1.48 M $6.26 M   2.37% 5.49%
FMR LLC 02/13/2025 1.27 M $5.35 M   -46.44% 4.69%
VANGUARD GROUP INC 02/11/2025 1.23 M $5.20 M   -3.44% 4.56%
FRANKLIN RESOURCES INC 02/12/2025 1.16 M $4.92 M   -4.76% 4.31%
CITADEL ADVISORS LLC 02/14/2025 975,986 $4.13 M   100.00% 3.62%
VESTAL POINT CAPITAL, LP 02/14/2025 915,000 $3.87 M   40.77% 3.39%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 844,823 $3.58 M   4.49% 3.13%
MARSHALL WACE, LLP 02/13/2025 837,374 $3.54 M   100.00% 3.11%
AWM INVESTMENT COMPANY, INC. 02/18/2025 687,831 $2.91 M   22.89% 2.55%
72 INVESTMENT HOLDINGS, LLC 02/14/2025 667,778 $2.82 M   0.00% 2.48%
ARMISTICE CAPITAL, LLC 02/14/2025 650,000 $2.75 M   100.00% 2.41%
WOODLINE PARTNERS LP 02/14/2025 621,976 $2.63 M   397.58% 2.31%
NORTHERN TRUST CORP 02/14/2025 587,135 $2.48 M   198.12% 2.18%
ALKEON CAPITAL MANAGEMENT LLC 02/14/2025 477,101 $2.02 M   -48.97% 1.77%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 472,657 $2.00 M   0.57% 1.75%
CANTOR FITZGERALD, L. P. 02/14/2025 375,000 $1.58 M   100.00% 1.39%
IKARIAN CAPITAL, LLC 02/14/2025 350,000 $1.48 M   100.00% 1.30%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 300,000 $1.27 M   100.00% 1.11%
ALMITAS CAPITAL LLC 02/14/2025 266,912 $1.13 M   100.00% 0.99%
ORBIMED ADVISORS LLC 02/14/2025 250,000 $1.06 M   100.00% 0.93%
MORGAN STANLEY 02/14/2025 202,641 $857,172   166.07% 0.75%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 154,831 $654,935   -17.19% 0.57%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 139,953 $592,001   -30.46% 0.52%
STIFEL FINANCIAL CORP 02/13/2025 128,700 $544,410   100.00% 0.48%
GOLDMAN SACHS GROUP INC 02/11/2025 111,277 $470,702   144.37% 0.41%
TD ASSET MANAGEMENT INC 02/11/2025 110,792 $468,650   43.90% 0.41%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 103,100 $436,113   100.00% 0.38%
WETHERBY ASSET MANAGEMENT INC 02/14/2025 84,162 $356,006   0.00% 0.31%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 77,146 $326,328   27.23% 0.29%
IEQ CAPITAL, LLC 02/03/2025 65,189 $275,749   0.00% 0.24%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 62,391 $263,914   -5.19% 0.23%
BANK OF AMERICA CORP /DE/ 02/14/2025 56,532 $239,130   63.74% 0.21%
LMR PARTNERS LLP 02/14/2025 51,700 $218,691   100.00% 0.19%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/14/2025 48,229 $204,009   100.00% 0.18%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 41,500 $175,545   100.00% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 40,926 $173,117   100.00% 0.15%
BARCLAYS PLC 02/13/2025 39,807 $168,000   34.49% 0.15%
CORTON CAPITAL INC. 02/14/2025 33,553 $141,929   100.00% 0.12%
TWO SIGMA INVESTMENTS, LP 02/14/2025 30,700 $129,861   137.25% 0.11%
RHUMBLINE ADVISERS 01/30/2025 25,556 $108,093   24.37% 0.09%
BROWN ADVISORY INC 02/14/2025 25,000 $105,750   100.00% 0.09%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 02/19/2025 22,175 $93,800   0.00% 0.08%
AMERIPRISE FINANCIAL INC 02/14/2025 22,015 $93,124   6.58% 0.08%
BOWIE CAPITAL MANAGEMENT, LLC 02/14/2025 19,484 $82,417   0.00% 0.07%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 02/10/2025 17,721 $74,428   100.00% 0.07%
CITIGROUP INC 02/12/2025 16,849 $71,272   8.94% 0.06%
CITADEL ADVISORS LLC 02/14/2025 16,300 $68,949   579.17% 0.06%
CITADEL ADVISORS LLC 02/14/2025 12,900 $54,567   -67.99% 0.05%

Alto Neuroscience, Inc. institutional Ownership - FAQ's

During the previous two years, 79 institutional investors and hedge funds held shares of Alto Neuroscience, Inc.. The most heavily invested institutionals were:

Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0

Alpha Wave Global, LP: 3.71 M

Point72 Asset Management, L.P.: 1.69 M

BlackRock, Inc.: 1.48 M

FMR LLC: 1.27 M

VANGUARD GROUP INC: 1.23 M

82.31% of Alto Neuroscience, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 22.11 M shares in the last 24 months. This purchase volume represents approximately $50.41 M in transactions.